Piroska Pázmány , Anna Kanjo , Zsanett Macht-Szalai , Noémi Gede , Nelli Farkas , Bálint Erőss , Andrea Szentesi , Áron Vincze , Roland Hagendorn , Zsolt Márton , Andrea Párniczky , Péter Hegyi , Zsolt Molnár
{"title":"急性胰腺炎的三级重症监护管理。","authors":"Piroska Pázmány , Anna Kanjo , Zsanett Macht-Szalai , Noémi Gede , Nelli Farkas , Bálint Erőss , Andrea Szentesi , Áron Vincze , Roland Hagendorn , Zsolt Márton , Andrea Párniczky , Péter Hegyi , Zsolt Molnár","doi":"10.1016/j.pan.2024.11.021","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction and aims</h3><div>Acute pancreatitis (AP) can rapidly progress from a stable condition to multiple organ failure with high mortality. We aimed to describe the characteristics of AP patients requiring admission to a critical care facility and to identify predictors of disease progression.</div></div><div><h3>Methods</h3><div>We conducted a post-hoc analysis using prospectively collected data from AP patients admitted to the high dependency unit (HDU) and intensive care unit (ICU) at the University of Pécs, Hungary, from 2016 to 2019. Patients were categorized according to critical care needs and severity. Daily records of organ function, organ support and laboratory parameters were kept. Descriptive analysis and predictive models were developed to forecast the need for escalated critical care and mortality.</div></div><div><h3>Results</h3><div>Analysis of 92 cases (65 % male, mean age 63 (range 19–92) years) revealed a median critical care stay of 8 days (range 1–69) and a mortality rate of 47 %. Naive Bayes prediction models using admission C-reactive protein (CRP) and amylase levels achieved 75 % accuracy in predicting mortality and a 65 % probability of requiring HDU and/or ICU admission. CRP levels increased significantly (47 vs 62 mg/l, p: 0.015) from 48 to 24 h before critical care admission, contrasting with controls, resulting in significantly higher CRP levels in critical care patients (62 vs 32 mg/l, p: 0.007) 24 h before admission.</div></div><div><h3>Conclusion</h3><div>Our findings suggest that on-admission CRP and amylase cannot reliably predict progression of AP. However, elevated and increasing levels of CRP and amylase may indicate the need for early HDU admission to enable closer monitoring.</div></div>","PeriodicalId":19976,"journal":{"name":"Pancreatology","volume":"25 1","pages":"Pages 39-47"},"PeriodicalIF":2.8000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Three-tiered critical care management of acute pancreatitis\",\"authors\":\"Piroska Pázmány , Anna Kanjo , Zsanett Macht-Szalai , Noémi Gede , Nelli Farkas , Bálint Erőss , Andrea Szentesi , Áron Vincze , Roland Hagendorn , Zsolt Márton , Andrea Párniczky , Péter Hegyi , Zsolt Molnár\",\"doi\":\"10.1016/j.pan.2024.11.021\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction and aims</h3><div>Acute pancreatitis (AP) can rapidly progress from a stable condition to multiple organ failure with high mortality. We aimed to describe the characteristics of AP patients requiring admission to a critical care facility and to identify predictors of disease progression.</div></div><div><h3>Methods</h3><div>We conducted a post-hoc analysis using prospectively collected data from AP patients admitted to the high dependency unit (HDU) and intensive care unit (ICU) at the University of Pécs, Hungary, from 2016 to 2019. Patients were categorized according to critical care needs and severity. Daily records of organ function, organ support and laboratory parameters were kept. Descriptive analysis and predictive models were developed to forecast the need for escalated critical care and mortality.</div></div><div><h3>Results</h3><div>Analysis of 92 cases (65 % male, mean age 63 (range 19–92) years) revealed a median critical care stay of 8 days (range 1–69) and a mortality rate of 47 %. Naive Bayes prediction models using admission C-reactive protein (CRP) and amylase levels achieved 75 % accuracy in predicting mortality and a 65 % probability of requiring HDU and/or ICU admission. CRP levels increased significantly (47 vs 62 mg/l, p: 0.015) from 48 to 24 h before critical care admission, contrasting with controls, resulting in significantly higher CRP levels in critical care patients (62 vs 32 mg/l, p: 0.007) 24 h before admission.</div></div><div><h3>Conclusion</h3><div>Our findings suggest that on-admission CRP and amylase cannot reliably predict progression of AP. However, elevated and increasing levels of CRP and amylase may indicate the need for early HDU admission to enable closer monitoring.</div></div>\",\"PeriodicalId\":19976,\"journal\":{\"name\":\"Pancreatology\",\"volume\":\"25 1\",\"pages\":\"Pages 39-47\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pancreatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1424390324008068\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pancreatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1424390324008068","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
简介和目的:急性胰腺炎(AP)可由病情稳定迅速发展为多器官功能衰竭,死亡率高。我们的目的是描述需要入住重症监护机构的AP患者的特征,并确定疾病进展的预测因素。方法:我们对2016年至2019年匈牙利paccimcs大学高依赖病房(HDU)和重症监护病房(ICU)住院的AP患者的前瞻性数据进行了事后分析。根据重症监护需要和严重程度对患者进行分类。保存器官功能、器官支持及实验室参数的日常记录。开发了描述性分析和预测模型来预测升级的重症监护和死亡率的需求。结果:对92例患者(65%为男性,平均年龄63岁(19-92岁))的分析显示,中位重症监护时间为8天(1-69天),死亡率为47%。使用入院c反应蛋白(CRP)和淀粉酶水平的朴素贝叶斯预测模型预测死亡率的准确率为75%,需要HDU和/或ICU住院的概率为65%。与对照组相比,重症监护患者入院前48至24小时CRP水平显著升高(47 vs 62 mg/l, p: 0.015),导致重症监护患者入院前24小时CRP水平显著升高(62 vs 32 mg/l, p: 0.007)。结论:我们的研究结果表明,入院时CRP和淀粉酶不能可靠地预测AP的进展。然而,CRP和淀粉酶水平的升高和增加可能表明需要早期HDU入院以进行更密切的监测。
Three-tiered critical care management of acute pancreatitis
Introduction and aims
Acute pancreatitis (AP) can rapidly progress from a stable condition to multiple organ failure with high mortality. We aimed to describe the characteristics of AP patients requiring admission to a critical care facility and to identify predictors of disease progression.
Methods
We conducted a post-hoc analysis using prospectively collected data from AP patients admitted to the high dependency unit (HDU) and intensive care unit (ICU) at the University of Pécs, Hungary, from 2016 to 2019. Patients were categorized according to critical care needs and severity. Daily records of organ function, organ support and laboratory parameters were kept. Descriptive analysis and predictive models were developed to forecast the need for escalated critical care and mortality.
Results
Analysis of 92 cases (65 % male, mean age 63 (range 19–92) years) revealed a median critical care stay of 8 days (range 1–69) and a mortality rate of 47 %. Naive Bayes prediction models using admission C-reactive protein (CRP) and amylase levels achieved 75 % accuracy in predicting mortality and a 65 % probability of requiring HDU and/or ICU admission. CRP levels increased significantly (47 vs 62 mg/l, p: 0.015) from 48 to 24 h before critical care admission, contrasting with controls, resulting in significantly higher CRP levels in critical care patients (62 vs 32 mg/l, p: 0.007) 24 h before admission.
Conclusion
Our findings suggest that on-admission CRP and amylase cannot reliably predict progression of AP. However, elevated and increasing levels of CRP and amylase may indicate the need for early HDU admission to enable closer monitoring.
期刊介绍:
Pancreatology is the official journal of the International Association of Pancreatology (IAP), the European Pancreatic Club (EPC) and several national societies and study groups around the world. Dedicated to the understanding and treatment of exocrine as well as endocrine pancreatic disease, this multidisciplinary periodical publishes original basic, translational and clinical pancreatic research from a range of fields including gastroenterology, oncology, surgery, pharmacology, cellular and molecular biology as well as endocrinology, immunology and epidemiology. Readers can expect to gain new insights into pancreatic physiology and into the pathogenesis, diagnosis, therapeutic approaches and prognosis of pancreatic diseases. The journal features original articles, case reports, consensus guidelines and topical, cutting edge reviews, thus representing a source of valuable, novel information for clinical and basic researchers alike.